OXFORD IMMUNOTEC GLOBAL PLC's ticker is OXFD and the CUSIP is G6855A103. A total of 73 filers reported holding OXFORD IMMUNOTEC GLOBAL PLC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $172,000 | +29.3% | 10,038 | -3.4% | 0.00% | – |
| Q4 2018 | $133,000 | -19.4% | 10,395 | +1.8% | 0.00% | – |
| Q3 2018 | $165,000 | +25.0% | 10,213 | -0.0% | 0.00% | – |
| Q2 2018 | $132,000 | -17.5% | 10,218 | +7.6% | 0.00% | – |
| Q3 2017 | $160,000 | -16.7% | 9,492 | -17.2% | 0.00% | – |
| Q2 2017 | $192,000 | +7.9% | 11,458 | 0.0% | 0.00% | – |
| Q1 2017 | $178,000 | -4.8% | 11,458 | -9.3% | 0.00% | – |
| Q4 2016 | $187,000 | +61.2% | 12,638 | +37.7% | 0.00% | – |
| Q3 2016 | $116,000 | +11500.0% | 9,180 | +12475.3% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 73 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | -66.7% | 73 | -54.4% | 0.00% | – |
| Q2 2014 | $3,000 | – | 160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 852,497 | $11,909,000 | 5.57% |
| Endurant Capital Management LP | 570,425 | $7,969,000 | 2.44% |
| First Light Asset Management, LLC | 596,778 | $8,337,000 | 2.29% |
| Grandeur Peak Global Advisors, LLC | 783,203 | $10,941,000 | 1.42% |
| Consonance Capital Management LP | 1,119,887 | $15,645,000 | 1.41% |
| Redmile Group, LLC | 2,318,387 | $32,388,000 | 1.41% |
| Birchview Capital, LP | 127,303 | $1,778,000 | 1.04% |
| RTW INVESTMENTS, LP | 375,792 | $5,250,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,264,000 | $17,658,000 | 0.70% |
| Granahan Investment Management | 515,277 | $7,198,000 | 0.57% |